Detection of 94 compounds related to sexual enhancement including sildenafil, tadalafil, vardenafil and their analogues in various formulations of dietary supplements and food samples using HPLC and LC-MS/MS

References

• Bakota EL, Kelly AT, Walterscheid JP, Phatak DR 2017. A Case report of fatal desmethyl carbodenafil toxicity. J Anal Toxicol. 41:250–255.
   Google Scholar
• Biesterbos JWH, Sijm DTHM, van Dam R, Mol HGJ. 2019. A health risk for consumers: the presence of adulterated food supplements in the Netherlands. Food Addit Contam Part A. 36(9):1273–1288. doi:10.1080/19440049.2019.1633020.
   PubMedGoogle Scholar
• Bujang NB, Chee CF, Heh CH, Rahman NA, Buckle MJC. 2017. Phosphodiesteratse-5 inhibitors and their analogues as adulterants of herbal and food products: analysis of the Malaysian market in 2014-2016. Food Addit Contam Part A. 34(7):1101–1109. doi:10.1080/19440049.2017.1336674.
   PubMed Web of Science ®Google Scholar
• Chan TYK. 2009. Outbreaks of severe hypoglycaemia due to illegal sexual enhancement products containing undeclared glibenclamide. Pharmacoepidemiol Drug Saf. 18:1250–1251. doi:10.1002/pds.1880.
   PubMed Web of Science ®Google Scholar
• Gilard V, Balayssac S, Tinaugus A, Martins N, Martino R, Malet-Martino M. 2015. Detection, identification and quantification by 1H NMR of adulterants in 150 herbal dietary supplements marketed for improving sexual performance. J Pharm Biomed Anal. 102:476–493. doi:10.1016/j.jpba.2014.10.011.
   PubMed Web of Science ®Google Scholar
• Glina S, Toscano I, Gomatzky C, de Goes PM, Junior AN, Claro JF, Pagani E. 2009. Efficacy and tolerability of lodenafil carbonate for oral therapy in erectile dysfunction: a phase II clinical trial. J Sex Med. 6(2):553–557. doi:10.1111/j.1743-6109.2008.01079.x.
   PubMed Web of Science ®Google Scholar
• Gresser U, Gleiter CH. 2002. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil, and tadalafil review of the literature. Eur J Med Res. 7(10):435–446.
   PubMed Web of Science ®Google Scholar
• Gu Y, Hu Q, Sun J, Yu H, Pan H, Zhao X, Ji S. 2020. Isolation and identification of a new sildenafil analogue, hydroxycarbodenafil, found as an adulterant in a health supplement. J Pharm Biomed Anal. 185:113222. doi:10.1016/j.jpba.2020.113222.
   PubMed Web of Science ®Google Scholar
• [ICH] International Conference Harmonisation. 2005. Harmonized tripartite guideline, validation of analytical procedures: text and methodology Q2 (R1). London (United Kingdom).
   Google Scholar
• Kee CL, Chin LC, Cheah NP, Ge X, Low MY. 2019. Elucidation of the absolute configuration of a tadalafil analogue found as adulterant in a health supplement by mass spectrometry, chiroptical methods and NMR spectroscopy. J Pharm Biomed Anal. 173:47–55. doi:10.1016/j.jpba.2019.05.010.
   PubMed Web of Science ®Google Scholar
• Kee CL, Ge X, Gilard V, Malet-Martino M, Low MY. 2018. A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements. J Pharm Biomed Anal. 147:250–277. doi:10.1016/j.jpba.2017.07.031.
   PubMed Web of Science ®Google Scholar
• Kessler A, Sollie S, Challacombe B, Briggs K, Hemelrijck MV. 2019. The global prevalence of erectile dysfunction: a review. BJU Int. 124(4):587–599. doi:10.1111/bju.14813.
   PubMed Web of Science ®Google Scholar
• Laumann EO, West S, Glasser D, Carson C, Rosen R, Kang JH. 2007. Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: from the male attitudes regarding sexual health survey. J Sex Med. 4(1):57–65. doi:10.1111/j.1743-6109.2006.00340.x.
   PubMed Web of Science ®Google Scholar
• Le TV, Tsambarils P, Hellstrom WJG. 2019. Pharmacodynamics of the agents used for the treatment of erectile dysfunction. Expert Opin Drug Metab Toxicol. 15(2):121–131. doi:10.1080/17425255.2019.1560421.
   PubMed Web of Science ®Google Scholar
• Lee JH, Park HN, Park OR, Kim NS, Park SK, Kang HI. 2019a. Screening of illegal sexual enhancement supplements and counterfeit drugs sold in the online and offline markets between 2014 and 2017. Forensic Sci Int. 298:10–19. doi:10.1016/j.forsciint.2019.02.014.
   PubMed Web of Science ®Google Scholar
• Lee JH, Park HN, Park S, Lee YM, Kang H. 2019b. Development of a specific fragment pattern-based quadrupole-Orbitrap mass spectrometry method to screen adulterated products of phosphodiesterase-5 inhibitors and their analogues. Sci Justice. 59(4):433–441. doi:10.1016/j.scijus.2019.02.006.
   PubMed Web of Science ®Google Scholar
• Marcus DM. 2016. Dietary supplements: what’s in a name? What’s in the bottle? Drug Test Anal. 8(3–4):410–412. doi:10.1002/dta.1855.
   PubMed Web of Science ®Google Scholar
• Mohd Yusop AY, Xiao L, Fu S. 2020. Suspected‐target and non‐targeted screenings of phosphodiesterase 5 (PDE5) inhibitors in herbal remedies by liquid chromatography–quadrupole time‐of‐flight–mass spectrometry (LC-QTOF-MS). Drug Test Anal. 1–12. doi:10.1002/dta.2861.
   Google Scholar
• Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH. 1998. Clinical safety of oral sildenafil citrate (VIAGRATM) in the treatment of erectile dysfunction. Int J Impot Res. 10:69–74. doi:10.1038/sj.ijir.3900354.
   PubMed Web of Science ®Google Scholar
• Paick JS, Ahn TY, Choi HK, Chung WS, Kim JJ, Kim SC, Kim SW, Lee SW, Min KS, Moon KH, et al. 2008a. Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction. J Sex Med. 5(11):2672–2680. doi:10.1111/j.1743-6109.2008.00945.x.
   PubMed Web of Science ®Google Scholar
• Paick JS, Kim SW, Yang DY, Kim JJ, Lee SW, Ahn TY, Choi HK, Suh JK, Kim SC. 2008b. The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. J Sex Med. 5(4):946–953. doi:10.1111/j.1743-6109.2007.00723.x.
   PubMed Web of Science ®Google Scholar
• Reepmeyer JC, Woodruff JT. 2006. Use of liquid chromatography–mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a “natural” herbal dietary supplement. J Chromatogr A. 1125(1):67–75. doi:10.1016/j.chroma.2006.05.018.
   PubMed Web of Science ®Google Scholar
• Smith KM, Romanelli F. 2005. Recreational use and misuse of phosphodiesterase 5 inhibitors. J Am Pharm Assoc. 45(1):63–72. doi:10.1331/1544345052843165.
   Google Scholar
• Srivatsav A, Balasubramanian A, Pathak UI, Rivere-Mirabal J, Thirumavalavan N, Hotaling JM, Lipshultz LI, Pastuszak AW. 2020. Efficacy and safety of common ingredients in aphrodisiacs used for erectile dysfunction: a review. Sex Med Rev. 8(3):431–442. doi:10.1016/j.sxmr.2020.01.001.
   PubMed Web of Science ®Google Scholar
• Tan JK, Hong CY, Png DJ, Liew LC, Wong ML. 2003. Erectile dysfunction in Singapore: prevalence and its associated factors-a population-based study. Singapore Med J. 44(1):20–26.
   PubMedGoogle Scholar
• Tiwari S. 2020. A comparative review on avanafil vs tadalafil vs sildenafil tablet. J Pharm Sci & Res. 12(5):598–601.
   Google Scholar
• Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M. 2018. Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Durg Administration warnings. JAMA Network Open. 1(6):e183337. doi:10.1001/jamanetworkopen.2018.3337.
   PubMed Web of Science ®Google Scholar
• Tzoumas N, Farrah TE, Dhaun N, Webb DJ. 2019. Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease. Br J Pharmaco. 1–22. doi:10.1111/bph.14920.
   Web of Science ®Google Scholar
• Venhuis BJ, Kaste D. 2012. Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: A history, analytical aspects and health risks. J Pharm Biomed Anal. 69:196–208. doi:10.1016/j.jpba.2012.02.014.
   PubMed Web of Science ®Google Scholar
• Venhuis BJ, Zwaagstra ME, van den Berg JDJ, van Riel AJHP, Wagenaar HWG, van Grootheest K, Barends DM, de Kaste D. 2010. Illicit erectile dysfunction products in the Netherlands: a decade of trends and a 2007-2010 product update. RIVM report 370030003/2010. National Institute for Public Health and the Environment; pp. 75.
   Google Scholar
• Zhang X, Yang B, Li N, Li H. 2017. Prevalence and risk factors for erectile dysfunction in Chinese adult males. J Sex Med. 14(10):1201–1208. doi:10.1016/j.jsxm.2017.08.009.
   PubMed Web of Science ®Google Scholar